ACTION POTENTIAL VENTURE CAPITAL LIMITED
Get an alert when ACTION POTENTIAL VENTURE CAPITAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-10-13 (in 5mo)
Last made up 2025-09-29
Watchouts
None on the register
Cash
£204K
-74.8% vs 2023
Net assets
-£55M
-1,351% vs 2023
Employees
—
Average over period
Profit before tax
-£10M
-36.3% vs 2023
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | -£1,237,954 | -£2,692,365 | |
| Profit before tax | -£7,154,188 | -£9,754,633 | |
| Net profit | -£5,481,097 | -£7,682,728 | |
| Cash | £809,489 | £203,855 | |
| Total assets less current liabilities | -£318,755 | -£55,085,248 | |
| Net assets | -£3,799,852 | -£55,134,915 | |
| Equity | -£3,799,852 | -£55,134,915 | |
| Average employees | — | — | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Return on capital employed | 388.4% | 4.9% | |
| Gearing (liabilities / total assets) | 103.0% | 163.4% | |
| Current ratio | 0.02x | 0.02x | |
| Interest cover | -0.21x | -0.38x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Having assessed the principal risks of the Company and other matters, the Directors are of the opinion that the current level of activity remains sustainable. ... The Directors believe that it remains appropriate to adopt the going concern basis of accounting in preparing the financial statements.”
Significant events
- “Subsequent to the reporting period, the Company entered into an agreement to sell six of its investment portfolios in exchange for a limited partner interest in a newly established fund. As of the approval date of these financial statements, the transaction has not yet been finalised. The anticipated closing of the transaction is expected to occur during the fourth quarter of 2025.”
- “The carrying value of the portfolios as of the balance sheet date was $83,459,000. It is expected that the completion of this transaction could result in a loss, although the exact amount cannot be determined at this time, as it is contingent upon the closing of the transaction and the final terms agreed upon. Any resulting loss will be recognised upon completion and recorded within other comprehensive income.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 4 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Secretary | 2013-07-10 | — | — |
| WALKER, Adam | Director | 2015-06-03 | Nov 1967 | British |
| WILLIAMS, Subesh Ronald | Director | 2019-04-26 | May 1962 | British |
| GLAXO GROUP LIMITED | Corporate Director | 2013-07-10 | — | — |
| THE WELLCOME FOUNDATION LIMITED | Corporate Director | 2013-07-10 | — | — |
Show 4 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BLACKBURN, Paul Frederick | Director | 2013-07-10 | 2016-03-01 |
| ECKSTEIN, Jens, Dr | Director | 2013-09-10 | 2019-05-31 |
| LYNCH, Ciara Martha | Director | 2020-03-02 | 2025-12-31 |
| PANAGIOTIDIS, Charalampos | Director | 2019-02-15 | 2020-03-02 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Glaxo Group Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 49 total filings
Material constitutional events — rename, articles re-file, resolution
- 2022-06-06 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-06 | TM01 | officers | Termination director company with name termination date | |
| 2025-09-30 | AA | accounts | Accounts with accounts type full | |
| 2025-09-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-04 | CH01 | officers | Change person director company with change date | |
| 2024-10-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-09-23 | CH01 | officers | Change person director company with change date | |
| 2024-09-17 | CH01 | officers | Change person director company with change date | |
| 2024-09-17 | CH01 | officers | Change person director company with change date | |
| 2024-09-11 | CH02 | officers | Change corporate director company with change date | |
| 2024-07-18 | AD02 | address | Change sail address company with old address new address | |
| 2024-07-16 | AA | accounts | Accounts with accounts type full | |
| 2023-10-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-08-16 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-08-16 | CH02 | officers | Change corporate director company with change date | |
| 2023-06-30 | AA | accounts | Accounts with accounts type full | |
| 2023-06-09 | AD02 | address | Change sail address company with new address | |
| 2023-06-06 | AD01 | address | Change registered office address company with date old address new address | |
| 2022-10-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-08-03 | AA | accounts | Accounts with accounts type full | |
| 2022-06-06 | RESOLUTIONS | resolution | Resolution |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
-74.8%
£809,489 £203,855
-
Net assets
-1,351%
-£3,799,852 -£55,134,915
-
Employees
—
Not reported
-
Operating profit
-117.5%
-£1,237,954 -£2,692,365
-
Profit before tax
-36.3%
-£7,154,188 -£9,754,633
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers